Bogunia-Kubik, K.; Wojtowicz, W.; Swierkot, J.; Mielko, K.A.; Qasem, B.; Wielińska, J.; Sokolik, R.; Pruss, Ł.; Młynarz, P.
Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies. Int. J. Mol. Sci. 2021, 22, 7389.
https://doi.org/10.3390/ijms22147389
AMA Style
Bogunia-Kubik K, Wojtowicz W, Swierkot J, Mielko KA, Qasem B, Wielińska J, Sokolik R, Pruss Ł, Młynarz P.
Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies. International Journal of Molecular Sciences. 2021; 22(14):7389.
https://doi.org/10.3390/ijms22147389
Chicago/Turabian Style
Bogunia-Kubik, Katarzyna, Wojciech Wojtowicz, Jerzy Swierkot, Karolina Anna Mielko, Badr Qasem, Joanna Wielińska, Renata Sokolik, Łukasz Pruss, and Piotr Młynarz.
2021. "Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies" International Journal of Molecular Sciences 22, no. 14: 7389.
https://doi.org/10.3390/ijms22147389
APA Style
Bogunia-Kubik, K., Wojtowicz, W., Swierkot, J., Mielko, K. A., Qasem, B., Wielińska, J., Sokolik, R., Pruss, Ł., & Młynarz, P.
(2021). Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies. International Journal of Molecular Sciences, 22(14), 7389.
https://doi.org/10.3390/ijms22147389